PepGen Inc. (PEPG)
NASDAQ: PEPG · Real-Time Price · USD
4.960
-0.170 (-3.31%)
At close: Oct 6, 2025, 4:00 PM EDT
4.979
+0.019 (0.39%)
After-hours: Oct 6, 2025, 7:01 PM EDT
PepGen Employees
PepGen had 81 employees as of December 31, 2024. The number of employees increased by 17 or 26.56% compared to the previous year.
Employees
81
Change (1Y)
17
Growth (1Y)
26.56%
Revenue / Employee
n/a
Profits / Employee
-$1,196,481
Market Cap
340.94M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 81 | 17 | 26.56% |
Dec 31, 2023 | 64 | 19 | 42.22% |
Dec 31, 2022 | 45 | 14 | 45.16% |
Dec 31, 2021 | 31 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
PEPG News
- 4 days ago - PepGen Announces Oral Presentations at the 30th Annual International Congress of the World Muscle Society - Business Wire
- 10 days ago - PepGen Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters' Option to Purchase Additional Shares - Business Wire
- 11 days ago - PepGen Reports Highest Splicing Correction In Dystrophy Patients, Stock Doubles - Benzinga
- 11 days ago - PepGen Announces Pricing of $100 Million Public Offering - Business Wire
- 12 days ago - PepGen Announces Proposed Public Offering - Business Wire
- 12 days ago - PepGen Announces Highest Mean Splicing Correction Reported in DM1 Patients - Business Wire
- 2 months ago - PepGen Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights - Business Wire
- 2 months ago - SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PepGen - GlobeNewsWire